China’s dairy giant Feihe is expanding into Southeast Asia’s infant and children’s nutrition market with the launch of its AceKid range in Indonesia and the Philippines. With birth rates declining in China, Southeast Asia offers Feihe a new growth opportunity to strengthen its presence beyond its domestic market.
The company has recently introduced its AceKid series in Indonesia, featuring super‑premium infant formula priced between IDR 130,000–150,000 and IDR 300,000–360,000. The brand offers a range of nutritional variants tailored to different stages of child development, including AceKid Plus Stage 1, Stage 2 and Stage 3, as well as AceKid Care Stage 1, Stage 2 and Stage 3.
Feihe claims its AceKid range is the first infant formula in Indonesia made with natural whole milk, featuring a traceable milk source and a one‑step fresh production process.
In the Philippines, the AceKid range includes AceKid Care Genumil Infant Formula (0–6 months), AceKid Care Genumil Follow‑up Formula (6–12 months), AceKid Plus Genugro Milk Supplement (1–3 years), and AceKid Activegrow Powdered Milk Drink (3+ years).
